Funding name
NANOPARTÍCULAS PARA EL TRATAMIENTO DE LA LEISHMANIOSIS
Acronym
120-2017
Funding code
120-2017
Parent funding
Expected Amount
55337
US Dollar
Executed amount
55337
US Dollar
Start Date
05 February 2018
End Date
05 July 2021